- In April 2023, Hologic, Inc., a leading innovator in women’s health, launched the Genius Digital Diagnostics System expansion for breast tomosynthesis, integrating artificial intelligence (AI) to enhance 3D image analysis and diagnostic accuracy. This system is designed to streamline radiology workflows while improving early breast cancer detection, particularly in women with dense breast tissue. The development underscores Hologic’s focus on leveraging AI-powered tools to improve clinical outcomes and solidify its leadership in breast imaging technologies
- In March 2023, GE HealthCare announced the commercial release of its upgraded Senographe Pristina with Serena Bright, a tomosynthesis-guided biopsy solution that allows for improved accuracy in lesion targeting. The innovation enhances patient comfort and enables radiologists to perform biopsies directly within the 3D mammography system. This advancement demonstrates GE’s commitment to providing holistic, minimally invasive breast care solutions and improving diagnostic precision across global screening programs
- In March 2023, Siemens Healthineers introduced AI enhancements to its Mammomat Revelation breast tomosynthesis system, focusing on improving detection capabilities and reducing the time required for image reading. These upgrades support radiologists by enabling quicker, more confident diagnoses, especially in high-volume screening environments. Siemens’ emphasis on AI-driven efficiency reflects the growing demand for technology that balances clinical performance with operational productivity
- In February 2023, iCAD, Inc. announced the deployment of its ProFound AI Risk platform across multiple hospitals in Europe and North America, enabling personalized risk assessments in conjunction with digital breast tomosynthesis. This development marks a shift toward more personalized screening protocols, where risk-based assessments guide the frequency and type of breast imaging. iCAD’s innovation illustrates the expanding role of AI in predictive diagnostics and breast cancer prevention strategies
- In January 2023, Planmed Oy, a Finland-based imaging company, showcased the Planmed Clarity 3D tomosynthesis system with low-dose imaging capabilities at Arab Health 2023. The system is designed to deliver high-quality images with minimal radiation exposure, meeting growing global demands for safer, patient-friendly diagnostics. This launch highlights Planmed’s dedication to radiation safety, accessibility, and technological advancement in emerging markets
